dangers of glp 1 drugs GI Adverse Effects Glucagon-Like Peptide-1 Receptor Agonists The GLP-1 Agonists and Obesity:
Description
Ferhatbegovi L et al
They dont replace these medications, but the required dose may go down
[DOI] [PubMed] [Google Scholar] 122.Becerril S, Frhbeck G
Accessed May 2018
They fail because of inconsistency
Regulating Adiponectin and Other Adipokines Adipokine dysregulation, which presents as hypoadiponectinaemia and hyperleptinaemia, contributes to the insulin resistance seen in T2DM
